Mutagenicity of nitrobenzyl derivatives: potential bioreductive anticancer agents

Author： Juneja T.R.   Bala A.   Kumar P.   Gupta R.L.  

Publisher： Elsevier

ISSN： 0165-7992

Source： Mutation Research Letters, Vol.348, Iss.3, 1995-11, pp. : 137-145

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potential mutagenicity, embryotoxicity, and teratogenicity of calcium ketopantoyl aminobutyrate

By Karaev A.   Treshchalin I.   Bodyagin D.   Pereverzeva E.   Kozlova G.   Gunar V.   Revazova Yu.   Yurchenko V.  

Bulletin of Experimental Biology and Medicine, Vol. 139, Iss. 1, 2005-01 ,pp. : 52-55

Springer Publishing Company

Access to resources Recommend Favorite

Effects of Ape1 Overexpression on Cellular Resistance to DNA-Damaging and Anticancer Agents

By Schild L.J.   Brookman K.W.   Thompson L.H.  

Somatic Cell and Molecular Genetics, Vol. 25, Iss. 5-6, 1999-11 ,pp. : 253-262

Springer Publishing Company

Access to resources Recommend Favorite

Antiapoptotic role of heme oxygenase (HO) and the potential of HO as a target in anticancer treatment

By Fang J.  

Apoptosis, Vol. 9, Iss. 1, 2004-01 ,pp. : 27-35

Springer Publishing Company

Access to resources Recommend Favorite

Are Aβ and Its Derivatives Causative Agents or Innocent Bystanders in AD?

By  

Neurodegenerative Diseases, Vol. 7, Iss. 1-3, 2010-02 ,pp. : 32-37

Karger

Access to resources Recommend Favorite

Bcl-2 attenuates anticancer agents-induced apoptosis by sustained activation of Akt/protein kinase B in U937 cells

By Woo K.   Yoo Y.   Park J.-W.   Kwon T.  

Apoptosis, Vol. 10, Iss. 6, 2005-12 ,pp. : 1333-1343

Springer Publishing Company

Access to resources Recommend Favorite